Engelson Erik T.
- SEC CIK
- 0001839384
No open-market purchases or sales filed in the past year.
Current role at each company
- LHDX Lucira Health, Inc.President and Chief Executiveas of Mar 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Engelson Erik T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 (view filing) | Mar 3 | 10 daysLate | Engelson Erik T.President and Chief Executive | SSale | −634.7K | $1.04 | −$657.3K | −96.5%23.3K after | 2 lots |
| Sep 19, 2022 (view filing) | Sep 15 | 4 days | Engelson Erik T.President and Chief Executive | PPurchase | +20.0K | $1.82 | +$36.4K | +31.6%83.3K after | |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Engelson Erik T.President and Chief Executive | PPurchase | +10.0K | $1.49 | +$14.9K | +18.8%63.3K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Engelson Erik T.President and Chief Executive | PPurchase | +30.0K | $3.00 | +$90.0K | +128.9%53.3K after |